We established an online registry of coronavirus disease–associated mucormycosis cases in India. We analyzed data from 65 cases diagnosed during April–June 2021, when the Delta variant predominated, and found that patients frequently received antibacterial drugs and zinc supplementation. Online registries rapidly provide relevant data for emerging infections.
All Keywords
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, Coronaviruses, Corticosteroids, India, Mucormycosis, fungal infections, fungi, fungus, 【초록키워드】 coronavirus disease, Zinc, coronavirus, India, drug, delta variant, infections, Mucormycosis, Patient, zinc supplementation, analyzed, diagnosed, 【제목키워드】 registry,
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, Coronaviruses, Corticosteroids, India, Mucormycosis, fungal infections, fungi, fungus, 【초록키워드】 coronavirus disease, Zinc, coronavirus, India, drug, delta variant, infections, Mucormycosis, Patient, zinc supplementation, analyzed, diagnosed, 【제목키워드】 registry,
우리는 인도에서 코로나바이러스 질병 관련 점막진균증 사례의 온라인 레지스트리를 구축했습니다. 델타 변이가 우세했던 2021년 4월부터 6월까지 진단된 65건의 데이터를 분석한 결과, 환자가 항생제와 아연 보충제를 자주 받는 것으로 나타났습니다. 온라인 레지스트리는 새로운 감염에 대한 관련 데이터를 신속하게 제공합니다.